276 related articles for article (PubMed ID: 25074285)
1. Fluconazole pharmacokinetics in a morbidly obese, critically ill patient receiving continuous venovenous hemofiltration.
Lopez ND; Phillips KM
Pharmacotherapy; 2014 Sep; 34(9):e162-8. PubMed ID: 25074285
[TBL] [Abstract][Full Text] [Related]
2. Fluconazole serum concentrations and pharmacokinetics in an obese patient.
Cohen LG; DiBiasio A; Lisco SJ; Hurford WE
Pharmacotherapy; 1997; 17(5):1023-6. PubMed ID: 9324192
[TBL] [Abstract][Full Text] [Related]
3. Effect of Obesity on the Population Pharmacokinetics of Fluconazole in Critically Ill Patients.
Alobaid AS; Wallis SC; Jarrett P; Starr T; Stuart J; Lassig-Smith M; Mejia JL; Roberts MS; Sinnollareddy MG; Roger C; Lipman J; Roberts JA
Antimicrob Agents Chemother; 2016 Nov; 60(11):6550-6557. PubMed ID: 27550344
[TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetic evaluation of voriconazole treatment in critically ill patients undergoing continuous venovenous hemofiltration.
Radej J; Krouzecky A; Stehlik P; Sykora R; Chvojka J; Karvunidis T; Novak I; Matejovic M
Ther Drug Monit; 2011 Aug; 33(4):393-7. PubMed ID: 21654349
[TBL] [Abstract][Full Text] [Related]
5. Population pharmacokinetics/pharmacodynamics of micafungin against Candida species in obese, critically ill, and morbidly obese critically ill patients.
Maseda E; Grau S; Luque S; Castillo-Mafla MP; Suárez-de-la-Rica A; Montero-Feijoo A; Salgado P; Gimenez MJ; García-Bernedo CA; Gilsanz F; Roberts JA
Crit Care; 2018 Apr; 22(1):94. PubMed ID: 29655372
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetic analysis of piperacillin administered with tazobactam in critically ill, morbidly obese surgical patients.
Sturm AW; Allen N; Rafferty KD; Fish DN; Toschlog E; Newell M; Waibel B
Pharmacotherapy; 2014 Jan; 34(1):28-35. PubMed ID: 23864417
[TBL] [Abstract][Full Text] [Related]
7. Population Pharmacokinetics of Cefuroxime in Critically Ill Patients Receiving Continuous Venovenous Hemofiltration With Regional Citrate Anticoagulation and a Phosphate-Containing Replacement Fluid.
Janssen PK; Foudraine NA; Burgers DM; Neef K; le Noble JL
Ther Drug Monit; 2016 Dec; 38(6):699-705. PubMed ID: 27494946
[TBL] [Abstract][Full Text] [Related]
8. Phenytoin removal by continuous venovenous hemofiltration.
Oltrogge KM; Peppard WJ; Saleh M; Regner KR; Herrmann DJ
Ann Pharmacother; 2013 Sep; 47(9):1218-22. PubMed ID: 24259740
[TBL] [Abstract][Full Text] [Related]
9. Influence of continuous veno-venous haemodiafiltration and continuous veno-venous haemofiltration on the pharmacokinetics of fluconazole.
Muhl E; Martens T; Iven H; Rob P; Bruch HP
Eur J Clin Pharmacol; 2000 Dec; 56(9-10):671-8. PubMed ID: 11214774
[TBL] [Abstract][Full Text] [Related]
10. Fluconazole dosing predictions in critically-ill patients receiving prolonged intermittent renal replacement therapy: a Monte Carlo simulation approach.
Gharibian KN; Mueller BA
Clin Nephrol; 2016 Jul; 86(7):43-50. PubMed ID: 27251341
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetics of meropenem in critically ill patients receiving continuous venovenous haemofiltration: a randomised controlled trial of continuous infusion versus intermittent bolus administration.
Jamal JA; Mat-Nor MB; Mohamad-Nor FS; Udy AA; Wallis SC; Lipman J; Roberts JA
Int J Antimicrob Agents; 2015 Jan; 45(1):41-5. PubMed ID: 25455853
[TBL] [Abstract][Full Text] [Related]
12. Pharmacokinetics of meropenem in critically ill patients with acute renal failure undergoing continuous venovenous hemofiltration.
Tegeder I; Neumann F; Bremer F; Brune K; Lötsch J; Geisslinger G
Clin Pharmacol Ther; 1999 Jan; 65(1):50-7. PubMed ID: 9951430
[TBL] [Abstract][Full Text] [Related]
13. Effect of continuous venovenous haemofiltration and haemodiafiltration on the elimination of fluconazole in patients with acute renal failure.
Valtonen M; Tiula E; Neuvonen PJ
J Antimicrob Chemother; 1997 Nov; 40(5):695-700. PubMed ID: 9421318
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics of fluconazole in critically ill patients with acute kidney injury receiving sustained low-efficiency diafiltration.
Sinnollareddy MG; Roberts MS; Lipman J; Robertson TA; Peake SL; Roberts JA
Int J Antimicrob Agents; 2015 Feb; 45(2):192-5. PubMed ID: 25455854
[TBL] [Abstract][Full Text] [Related]
15. Micafungin pharmacokinetic/pharmacodynamic adequacy for the treatment of invasive candidiasis in critically ill patients on continuous venovenous haemofiltration.
Maseda E; Grau S; Villagran MJ; Hernandez-Gancedo C; Lopez-Tofiño A; Roberts JA; Aguilar L; Luque S; Sevillano D; Gimenez MJ; Gilsanz F
J Antimicrob Chemother; 2014 Jun; 69(6):1624-32. PubMed ID: 24505092
[TBL] [Abstract][Full Text] [Related]
16. Vancomycin pharmacokinetics during high-volume continuous venovenous hemofiltration in critically ill septic patients.
Petejova N; Martinek A; Zahalkova J; Duricova J; Brozmannova H; Urbanek K; Grundmann M; Plasek J; Kacirova I
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2014; 158(1):65-72. PubMed ID: 23132513
[TBL] [Abstract][Full Text] [Related]
17. The pharmacokinetic profile of voriconazole during continuous high-volume venovenous hemofiltration in a critically ill patient.
Quintard H; Papy E; Massias L; Lasocki S; Arnaud P; Desmonts JM; Montravers P
Ther Drug Monit; 2008 Feb; 30(1):117-9. PubMed ID: 18223474
[TBL] [Abstract][Full Text] [Related]
18. Levetiracetam Pharmacokinetics in a Patient Receiving Continuous Venovenous Hemofiltration and Venoarterial Extracorporeal Membrane Oxygenation.
Nei SD; Wittwer ED; Kashani KB; Frazee EN
Pharmacotherapy; 2015 Aug; 35(8):e127-30. PubMed ID: 26242293
[TBL] [Abstract][Full Text] [Related]
19. Population pharmacokinetics of fluconazole in critically ill patients receiving continuous venovenous hemodiafiltration: using Monte Carlo simulations to predict doses for specified pharmacodynamic targets.
Patel K; Roberts JA; Lipman J; Tett SE; Deldot ME; Kirkpatrick CM
Antimicrob Agents Chemother; 2011 Dec; 55(12):5868-73. PubMed ID: 21930888
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetics of levofloxacin during continuous venovenous hemodiafiltration and continuous venovenous hemofiltration in critically ill patients.
Guenter SG; Iven H; Boos C; Bruch HP; Muhl E
Pharmacotherapy; 2002 Feb; 22(2):175-83. PubMed ID: 11837556
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
